27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Agile Therapeutics (NASDAQ:AGRX) rose in after-market trading after the company reported Q2 results.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Quarterly Results
Earnings per share fell 66.67% year over year to ($0.20), which beat the estimate of ($0.21).
Revenue of $1,185,000 higher by 0.00% from the same period last year, which missed the estimate of $1,950,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Agile Therapeutics hasn't issued any revenue guidance for the time being.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Details Of The Call
Date: Jul 26, 2021
Time: 04:30 PM
Price Action
Company's 52-week high was at $3.89
Company's 52-week low was at $1.07
Price action over last quarter: down 17.88%
Company Overview
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.